Children Vaccination of COVID-19

Authors

DOI:

https://doi.org/10.51200/bjms.v15i3.3357

Keywords:

COVID-19, Children Vaccination

Abstract

The Delta variant is currently the highly contagious predominant variant of the SARSCoV-2 virus worldwide that causes severe illness more than the previous variants in unvaccinated people (CDC, 2021). At a White House briefing, the National Institute of Allergy and Infectious Diseases director, Anthony Fauci, predicted that there would be an increase in the number of child hospitalisation proportionate to the increased number of children getting infected with the Delta variant (Press briefing White House, 2021). In response to this situation, the FDA (U.S. Food and Drug Administration) approved Pfizer-BioNTech and Moderna vaccines for children aged 12 – 17 years. Vaccines in children aged 5 – 11 years are currently under clinical trial (Sick-Samuels & Messina, 2021).

Author Biography

M Tanveer Hossain Parash, Department of Biomedical Science & Therapeutics, Faculty of Medicine & Health Sciences

Senior Lecturer

Published

2021-09-30

How to Cite

Shimmi, S. C., & Hossain Parash, M. T. (2021). Children Vaccination of COVID-19. Borneo Journal of Medical Sciences (BJMS), 15(3), 1–3. https://doi.org/10.51200/bjms.v15i3.3357
Total Views: 336 | Total Downloads: 167